Dabigatran is a pharmaceutical compound that functions as an active metabolite of the prodrug dabigatran etexilate. It is used in the manufacturing of anticoagulant medications for the prevention of stroke and systemic embolism.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 211914-51-1
Dabigatran ethyl ester
pharmaceutical intermediate
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
pharmaceutical raw material
Dabigatran etexilate
pharmaceutical raw material
Asciminib hydrochloride
pharmaceutical raw material
Calcitonin human
pharmaceutical raw material
(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
pharmaceutical raw material
Dabigatran impurity P
pharmaceutical intermediate
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
pharmaceutical intermediate
3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
YBSJFWOBGCMAKL-UHFFFAOYSA-N
CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N